GPSai AI algorithm may help identify and correct misdiagnoses of cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

By including AI algorithms as part of routine comprehensive molecular profiling, clinicians can uncover clinically significant misdiagnoses in cases labeled as lung squamous cell carcinoma, influencing treatment decisions and patient outcomes, according to a multi-institutional study.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login